Detalhe da pesquisa
1.
Clonal Deletion of Tumor-Specific T Cells by Interferon-γ Confers Therapeutic Resistance to Combination Immune Checkpoint Blockade.
Immunity
; 50(2): 477-492.e8, 2019 02 19.
Artigo
em Inglês
| MEDLINE | ID: mdl-30737146
2.
Health-related quality of life and pain outcomes with [177Lu]Lu-PSMA-617 plus standard of care versus standard of care in patients with metastatic castration-resistant prostate cancer (VISION): a multicentre, open-label, randomised, phase 3 trial.
Lancet Oncol
; 24(6): 597-610, 2023 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-37269841
3.
Exploring new frontiers in prostate cancer research: Report from the 2022 Coffey-Holden prostate cancer academy meeting.
Prostate
; 83(3): 207-226, 2023 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-36443902
4.
Phase II trial of CV301 vaccine combined with atezolizumab in advanced urothelial carcinoma.
Cancer Immunol Immunother
; 72(3): 775-782, 2023 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-35998004
5.
Sequencing of PD-1/L1 Inhibitors and Carboplatin Based Chemotherapy for Cisplatin Ineligible Metastatic Urothelial Carcinoma.
J Urol
; 205(2): 414-419, 2021 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-32935617
6.
A model combining clinical and genomic factors to predict response to PD-1/PD-L1 blockade in advanced urothelial carcinoma.
Br J Cancer
; 122(4): 555-563, 2020 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-31857723
7.
A Phase II Trial of Selinexor, an Oral Selective Inhibitor of Nuclear Export Compound, in Abiraterone- and/or Enzalutamide-Refractory Metastatic Castration-Resistant Prostate Cancer.
Oncologist
; 23(6): 656-e64, 2018 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-29487219
8.
A Phase I Study of Abiraterone Acetate Combined with BEZ235, a Dual PI3K/mTOR Inhibitor, in Metastatic Castration Resistant Prostate Cancer.
Oncologist
; 22(5): 503-e43, 2017 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-28314838
9.
Treatment strategies in low-volume metastatic castration-resistant prostate cancer.
Curr Opin Urol
; 27(6): 596-603, 2017 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-28786849
10.
Randomized Phase II Study Evaluating the Addition of Pembrolizumab to Radium-223 in Metastatic Castration-resistant Prostate Cancer.
Cancer Immunol Res
; : OF1-OF15, 2024 Mar 29.
Artigo
em Inglês
| MEDLINE | ID: mdl-38552171
11.
IGF-1 axis changes with ADT and docetaxel in metastatic prostate cancer.
Endocr Relat Cancer
; 30(11)2023 Nov 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-37671811
12.
Circulating and Intratumoral Immune Determinants of Response to Atezolizumab plus Bevacizumab in Patients with Variant Histology or Sarcomatoid Renal Cell Carcinoma.
Cancer Immunol Res
; 11(8): 1114-1124, 2023 08 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-37279009
13.
Pretest Video Education Versus Genetic Counseling for Patients With Prostate Cancer: ProGen, A Multisite Randomized Controlled Trial.
JCO Oncol Pract
; 19(11): 1069-1079, 2023 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-37733980
14.
Outcomes in men with metastatic castration-resistant prostate cancer who received sipuleucel-T and no immediate subsequent therapy: experience at Dana Farber and in the PROCEED Registry.
Prostate Cancer Prostatic Dis
; 25(2): 314-319, 2022 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-35145218
15.
Biomarker-Based Phase II Study of Sapanisertib (TAK-228): An mTORC1/2 Inhibitor in Patients With Refractory Metastatic Renal Cell Carcinoma.
JCO Precis Oncol
; 6: e2100448, 2022 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-35171658
16.
A clinical-grade liquid biomarker detects neuroendocrine differentiation in prostate cancer.
J Clin Invest
; 132(21)2022 11 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-36317634
17.
Checkpoint kinase inhibitor synergizes with DNA-damaging agents in G1 checkpoint-defective neuroblastoma.
Int J Cancer
; 129(8): 1953-62, 2011 Oct 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-21154747
18.
An FHA domain-mediated protein interaction network of Rad53 reveals its role in polarized cell growth.
J Cell Biol
; 175(5): 743-53, 2006 Dec 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-17130285
19.
Phase II Multicenter Study of Enzalutamide in Metastatic Castration-Resistant Prostate Cancer to Identify Mechanisms Driving Resistance.
Clin Cancer Res
; 27(13): 3610-3619, 2021 07 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-33849963
20.
Development and initial clinical testing of a multiplexed circulating tumor cell assay in patients with clear cell renal cell carcinoma.
Mol Oncol
; 15(9): 2330-2344, 2021 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-33604999